By Dr Jennifer Claire Massey

Journal articles

Childs S; Ma D; Houghton E; Cosman R; Massey J; Chin V; Valencia V; O’Grady A; Jensen SK; McLaughlin A; Goodwin S; Tao H; Withers B; Noakes C; Horne A; Preisz P; Boyd J; Forstner D; Rodrigues A; Sandhu G; Ibrahim K; Martin C; Kwan B; De Luca N; Buscher H; Cunningham P; Joshua AM; Girgis L; Tran B; Desai J; Harrison SJ; Moore J; Liu J, 2026, 'A roadmap for establishing institutional readiness for cellular therapies targeting solid tumours and autoimmune diseases', Npj Precision Oncology, 10, http://dx.doi.org/10.1038/s41698-026-01462-6

Sutton I; Massey J, 2026, 'A viral aetiology for multiple sclerosis: In pursuit of Kurtzke's dark horse', Multiple Sclerosis and Related Disorders, 114, http://dx.doi.org/10.1016/j.msard.2026.107411

Yazar S; Schwab N; Sanderson NSR; Massey J, 2026, 'The EBV-autoimmunity axis: mechanistic insights in SLE, MS and PSC', Immunology and Cell Biology, 104, pp. 590 - 594, http://dx.doi.org/10.1111/imcb.70127

Kalincik T; Sharmin S; Roos I; Freedman MS; Atkins H; Massey J; Sutton I; Withers B; Burman J; Torkildsen Ø; Bø L; Lehmann AK; Havrdova EK; Krasulova E; Trneny M; Kozak T; Macdonell R; Brown WJL; Coles A; van der Walt A; Butzkueven H; Van Wijmeersch B; Lechner-Scott J; Barnett M; Laureys G; Willekens B; Buzzard K; Skibina O; Gregorio MD; Hodgkinson S; Ozakbas S; Meca-Lallana JE; Alroughani R; Prevost J; Foschi M; Surcinelli A; Neri S; Eichau S; McCombe P; John N; Cárdenas-Robledo S; Oh J; Sanchez-Menoyo JL; Patti F; Gerlach O; Blanco Y; Grammond P; Sharrack B; Snowden JA, 2026, 'Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis', Brain, 149, pp. 951 - 962, http://dx.doi.org/10.1093/brain/awaf286

Raffoul DG; Roos I; Mulazzani M; Anderson MA; Monif M; Garber J; van der Walt A; Massey J; Kuznetsova V; Nesbitt C; Dowling M; Ruderman I; Lasocki A; Tam CS; Harrison SJ; Kalincik T, 2026, 'Neurological implications of chimeric antigen receptor-T cell therapy', BMJ Neurology Open, 8, pp. e001491, http://dx.doi.org/10.1136/bmjno-2025-001491

Greco R; Saccardi R; Ponzano M; Badoglio M; Helbig G; Smilowski M; Mariottini A; Burman J; Carlson K; Kazmi M; Muraro PA; Gabriel I; Withers B; Massey J; Varaldo R; Inglese M; Sanz J; Gil-Perotin S; Sharrack B; Roldan E; Nozzoli C; Signori A; Sormani MP; Alexander T; Snowden JA, 2025, 'BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party', Bone Marrow Transplantation, 60, pp. 1628 - 1634, http://dx.doi.org/10.1038/s41409-025-02715-x

Nitz C; Withers B; Ma DDF; Milliken ST; Moore JJ; Massey JC, 2025, 'Autologous haematopoietic stem cell transplantation in non-MS neuroimmunological diseases', Multiple Sclerosis and Related Disorders, 103, http://dx.doi.org/10.1016/j.msard.2025.106714

Nitz C; Carroll AS; Jude M; Massey J, 2025, 'Reaching new heights in neuroimmunology: a proposed model of care for the Murrumbidgee Local Health District', Internal Medicine Journal, 55, pp. 1695 - 1700, http://dx.doi.org/10.1111/imj.70166

Massey J; Monif M, 2025, 'Anti-B-cell CAR-T therapy in multiple sclerosis is simply a more profound immunoablation? Commentary', Multiple Sclerosis Journal, 31, pp. 1165 - 1166, http://dx.doi.org/10.1177/13524585251370085

Jokubaitis VG; Alroughani R; Altintas A; Eichau S; Hughes S; Willekens B; Horakova D; Havrdova EK; Ozakbas S; Boz C; Habek M; Kalincik T; Roos I; Etemadifar M; Peterka M; Lechner-Scott J; Meca-Lallana JE; Rous Z; Houskova J; Prat A; Girard M; Ampapa R; Buzzard K; Skibina O; John NA; Kermode AG; Fabis-Pedrini MJ; Foschi M; Surcinelli A; Blanco Y; Baghbanian SM; Gerlach O; Macdonell R; Pavelek Z; Stourac P; McCombe P; Laureys G; Butzkueven H; van der Walt A; Gray O; Vachova M; Libertinova J; Barnett M; Hradilek P; Duquette P; Martinkova A; Carroll WM; Recmanova E; Prevost J; Rath L; Izquierdo G; Moghadasi AN; Slee M; Maimone D; Oh J; Terzi M; Grammond P; Sanchez-Menoyo JL; D’Amico E; Ferrando BR; Yetkin MF; Yamout B; Stetkarova I; Ramo-Tello C; de Gans K; Gouider R; Mrabet S; Al-Asmi A; Karabudak R; Soysal A; Khoury SJ; Lapointe E; Cárdenas-Robledo S; Shalaby N; Spitaleri D; Guimarães J; Jakob GB; Hodgkinson S; Baghbanian M; Turkoglu R; van Pesch V; Grand’Maison F; Cartechini E; Gomez-Figueroa E; Massey J; Nohara C; Sakurai K; Mason D; Al-Harbi T; Castillo-Triviño T; Shimizu F; Taylor B; Hardy TA; Vucic S; Reddel S; Ramanathan S; Decoo D; de Vecino MCA; Nakamura Y; Chihara N, 2025, 'Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)', Multiple Sclerosis Journal, 31, pp. 1088 - 1101, http://dx.doi.org/10.1177/13524585251349125

Müller J; Sharmin S; Lorscheider J; Ozakbas S; Karabudak R; Horakova D; Weinstock-Guttman B; Shaygannejad V; Etemadifar M; Alroughani R; Patti F; Eichau S; Prat A; Lugaresi A; Tomassini V; Kermode AG; Amato MP; Turkoglu R; Altintas A; Buzzard K; Soysal A; Van Der Walt A; Butzkueven H; Blanco Y; Gerlach O; Khoury SJ; Barnett M; John N; Lechner-Scott J; Foschi M; Surcinelli A; Van Pesch V; Prevost J; Sa MJ; Maimone D; D'Hooghe M; Hughes S; Hodgkinson S; Mcguigan C; Cartechini E; Taylor B; Spitaleri D; Slee M; Mccombe P; Yamout B; Benkert P; Kuhle J; Kappos L; Roos I; Kalincik T; Havrdova EK; Girard M; Duquette P; Fabis-Pedrini M; Carroll WM; Skibina O; Gouider R; Mrabet S; Ramo-Tello C; Solaro C; Habek M; Van Wijmeersch B; Ampapa R; Macdonell R; Oreja-Guevara C; De Gans K; Laureys G; Oh J; Garber J; Gray O; Agüera-Morales E; Sanchez-Menoyo JL; Castillo-Triviño T; Grigoriadis N; Petersen T; Hardy TA; Vucic S; Reddel S; Ramanathan S; Al-Asmi A; Simu M; Baghbanian SM; Poehlau D; Al-Harbi T; Rojas JI; Deri N; Lalive P; Cambron M; Csepany T; Shuey N; Willekens B; Shaw C; Decoo D; Massey J; Yaldizli Ö; Derfuss T; Granziera C, 2025, 'Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis', JAMA Neurology, 82, pp. 614 - 625, http://dx.doi.org/10.1001/jamaneurol.2025.0495

Schneider-Hohendorf T; Wünsch C; Falk S; Raposo C; Rubelt F; Mirebrahim H; Asgharian H; Schlecht U; Mattox D; Zhou W; Dawin E; Pawlitzki M; Lauks S; Jarius S; Wildemann B; Havla J; Kümpfel T; Schrot MC; Ringelstein M; Kraemer M; Schwake C; Schmitter T; Ayzenberg I; Fischer K; Meuth SG; Aktas O; Hümmert MW; Kretschmer JR; Trebst C; Kleffner I; Massey J; Muraro PA; Chen-Harris H; Gross CC; Klotz L; Wiendl H; Schwab N, 2025, 'Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation', Brain, 148, pp. 933 - 940, http://dx.doi.org/10.1093/brain/awae244

Holmqvist KL; Strandberg T; Simpson G; Massey J; Matérne M, 2025, 'Content and outcome of non-pharmacological rehabilitation in hospital, or community-based care, for women with traumatic brain injury: a scoping review protocol.', BMJ Open, 15, pp. e092767, http://dx.doi.org/10.1136/bmjopen-2024-092767

Yin J; Kaakoush NO; Massey J; Danta M, 2025, 'Understanding the microbiome in autologous haemopoietic stem cell transplant for multiple sclerosis.', Front Immunol, 16, pp. 1590601, http://dx.doi.org/10.3389/fimmu.2025.1590601

Kalincik T; Sharmin S; Roos I; Massey J; Sutton I; Withers B; Freedman MS; Atkins H; Krasulova E; Kubala Havrdova E; Trneny M; Kozak T; Burman J; MacDonell R; Torkildsen Ø; Bø L; Lehmann AK; Sharrack B; Snowden J, 2024, 'Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis', Journal of Neurology Neurosurgery and Psychiatry, 95, pp. 775 - 783, http://dx.doi.org/10.1136/jnnp-2023-332790

Brown JD; Muston BT; Massey J, 2024, 'Switching from natalizumab to an anti-CD20 monoclonal antibody in relapsing remitting multiple sclerosis: A systematic review', Multiple Sclerosis and Related Disorders, 86, http://dx.doi.org/10.1016/j.msard.2024.105605

Pang V; Seery N; Wesselingh R; Yeh W; Zhong M; Tan T; Dwyer C; Nesbitt C; Rath L; Perera D; Bridge F; Skibina O; Bosco JJ; Jokubaitis V; Marriott M; Butkueven H; Van Der Walt A; Massey J; Sutton I; Monif M, 2024, 'Neutropaenia complications from Ocrelizumab and Rituximab treatment', Multiple Sclerosis and Related Disorders, 81, http://dx.doi.org/10.1016/j.msard.2023.105147

Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J, 2023, 'Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant', Cytotherapy, 25, pp. 1271 - 1276, http://dx.doi.org/10.1016/j.jcyt.2023.08.010

Sharmin S; Roos I; Simpson-Yap S; Malpas C; Sánchez MM; Ozakbas S; Horakova D; Havrdova EK; Patti F; Alroughani R; Izquierdo G; Eichau S; Boz C; Zakaria M; Onofrj M; Lugaresi A; Weinstock-Guttman B; Prat A; Girard M; Duquette P; Terzi M; Amato MP; Karabudak R; Grand’Maison F; Khoury SJ; Grammond P; Lechner-Scott J; Buzzard K; Skibina O; van der Walt A; Butzkueven H; Turkoglu R; Altintas A; Maimone D; Kermode A; Shalaby N; Pesch VV; Butler E; Sidhom Y; Gouider R; Mrabet S; Gerlach O; Soysal A; Barnett M; Kuhle J; Hughes S; Sa MJ; Hodgkinson S; Oreja-Guevara C; Ampapa R; Petersen T; Ramo-Tello C; Spitaleri D; McCombe P; Taylor B; Prevost J; Foschi M; Slee M; McGuigan C; Laureys G; Hijfte LV; de Gans K; Solaro C; Oh J; Macdonell R; Aguera-Morales E; Singhal B; Gray O; Garber J; Wijmeersch BV; Simu M; Castillo-Triviño T; Sanchez-Menoyo JL; Khurana D; Al-Asmi A; Al-Harbi T; Deri N; Fragoso Y; Lalive PH; Sinnige LGF; Shaw C; Shuey N; Csepany T; Sempere AP; Moore F; Decoo D; Willekens B; Gobbi C; Massey J; Hardy T; Parratt J; Kalincik T, 2023, 'The risk of secondary progressive multiple sclerosis is geographically determined but modifiable', Brain, 146, pp. 4633 - 4644, http://dx.doi.org/10.1093/brain/awad218

Massey J; Artuz C; Dyer Z; Jackson K; Khoo M; Visweswaran M; Withers B; Moore J; Ma D; Sutton I, 2023, 'Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis', Clinical Immunology, 254, http://dx.doi.org/10.1016/j.clim.2023.109709

Kalincik T; Sharmin S; Roos I; Freedman MS; Atkins H; Burman J; Massey J; Sutton I; Withers B; MacDonell R; Grigg A; Torkildsen Ø; Bo L; Lehmann AK; Havrdova EK; Krasulova E; Trněný M; Kozak T; Van Der Walt A; Butzkueven H; McCombe P; Skibina O; Lechner-Scott J; Willekens B; Cartechini E; Ozakbas S; Alroughani R; Kuhle J; Patti F; Duquette P; Lugaresi A; Khoury SJ; Slee M; Turkoglu R; Hodgkinson S; John N; Maimone D; Sa MJ; Van Pesch V; Gerlach O; Laureys G; Van Hijfte L; Karabudak R; Spitaleri D; Csepany T; Gouider R; Castillo-Triviño T; Taylor B; Sharrack B; Snowden JA; Mrabet S; Garber J; Sanchez-Menoyo JL; Aguera-Morales E; Blanco Y; Al-Asmi A; Weinstock-Guttman B; Fragoso Y; De Gans K; Kermode A, 2023, 'Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis', JAMA Neurology, 80, pp. 702 - 713, http://dx.doi.org/10.1001/jamaneurol.2023.1184

Dyer Z; Tscharke D; Sutton I; Massey J, 2023, 'From bedside to bench: how existing therapies inform the relationship between Epstein–Barr virus and multiple sclerosis', Clinical and Translational Immunology, 12, http://dx.doi.org/10.1002/cti2.1437

Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.798300

Visweswaran M; Hendrawan K; Massey JC; Khoo ML; Ford CD; Zaunders JJ; Withers B; Sutton IJ; Ma DDF; Moore JJ, 2022, 'Sustained immunotolerance in multiple sclerosis after stem cell transplant', Annals of Clinical and Translational Neurology, 9, pp. 206 - 220, http://dx.doi.org/10.1002/acn3.51510

Hendrawan K; Khoo MLM; Visweswaran M; Massey JC; Withers B; Sutton I; Ma DDF; Moore JJ, 2022, 'Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.782935

Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DDF; Moore JJ; Massey JC, 2021, 'Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis', Multiple Sclerosis Journal, 27, pp. 2112 - 2115, http://dx.doi.org/10.1177/13524585211005660

Almeida OP; Hankey GJ; Ford A; Etherton-Beer C; Flicker L; Hackett M; Massey J; Jan S; Delcourt C; Zagami A, 2021, 'Depression Outcomes among Patients Treated with Fluoxetine for Stroke Recovery: The AFFINITY Randomized Clinical Trial', JAMA Neurology, 78, pp. 1072 - 1079, http://dx.doi.org/10.1001/jamaneurol.2021.2418

Hankey GJ; Hackett ML; Almeida OP; Flicker L; Mead GE; Dennis MS; Etherton-Beer C; Ford AH; Billot L; Jan S; Lung T; Lundström E; Sunnerhagen KS; Anderson CS; Thang-Nguyen H; Gommans J; Yi Q, 2021, 'Twelve-Month Outcomes of the affinity trial of fluoxetine for functional recovery after acute stroke: Affinity trial steering committee on behalf of the AFFINITY Trial Collaboration', Stroke, pp. 2502 - 2509, http://dx.doi.org/10.1161/STROKEAHA.120.033070

Hankey GJ; Hackett ML; Almeida OP; Flicker L; Mead GE; Dennis MS; Etherton-Beer C; Ford AH; Billot L; Jan S; Lung T; Murray V; Lundström E; Anderson CS; Herbert R; Carter G; Donnan GA; Nguyen HT; Gommans J; Yi Q; Li Q; Bompoint S; Barrett S; Claxton A; O'Dea J; Tang M; Williams C; Peterson S; Drummond C; Hong UH; Le LTM; Ngo TTB; Mai YB; Han HT; Truong NQ; Nguyen HT; Ngo HT; Nguyen TB; Ha OTK; Nguyen TLH; Lindley RI; New P; Lee A; Tran TT; Le LTTM; Kieu TLV; Nguyen SV; Nguyen TAD; Dang TN; Phan HTT; Vo LTN; Nguyen MH; Dang HC; Tran HT; Dam LTC; Ngo TTK; Pham TNT; Pham BN; Dao NTT; Le LTC; Do CM; Huynh HQ; Tran GTK; Le OT; Tran LTK; Duong CD; Kieu DV; Le N; Nguyen HN; Le BV; Nguyen LT; Nguyen LV; Dinh TQ; Vo TV; Bui TN; Hoang UTT; Nguyen HTB; Nguyen HTT; Lam NT; Le KK; Trinh PT; Huynh HQ; Nguyen TTT; Lu HN; Pham TH; Nguyen SH; Le NH; Nguyen GT; Doan BT; Pham SP; Luong DH; Mai HV; Tran TV; Do PT; Le HT; Nguyen CV; Nguyen PD; Mai TD; Dao PV; Markus R; Calic Z; Katrak P; Faux S; Delcourt C; Carcel C; McDougall A; O'Rourke F; Cordato D; Jude M; Zagami A; Massey J, 2020, 'Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial', Lancet Neurology, 19, pp. 651 - 660, http://dx.doi.org/10.1016/S1474-4422(20)30207-6

Massey J; Barnett Y; Curnow J; Sutton I, 2019, 'B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple Sclerosis', Multiple Sclerosis and Related Disorders, 35, pp. 100 - 103, http://dx.doi.org/10.1016/j.msard.2019.07.016

Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF, 2019, 'Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis', Journal of Neurology Neurosurgery and Psychiatry, 90, pp. 514 - 521, http://dx.doi.org/10.1136/jnnp-2018-319446

Massey JC; Moore JJ; Milliken ST; F. DD, 2019, 'Autologous hematopoietic stem cell transplant for autoimmune diseases: evolution,evidence of efficacy, and real-world economics', BLOOD CELL THERAPY / The official journal of APBMT, 2, pp. 12 - 21, http://dx.doi.org/10.31547/bct-2018-009

Giarola B; Massey J; Barnett Y; Rodrigues M; Sutton I, 2019, 'Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis', Multiple Sclerosis and Related Disorders, 28, pp. 31 - 33, http://dx.doi.org/10.1016/j.msard.2018.12.004

Massey J; Walker S; Galloway M; Fernando S; Parratt J; Quigley AM; Kidd DP, 2019, 'Granulomatous CNS inflammation associated with seminoma', Journal of Neurology, 266, pp. 1389 - 1393, http://dx.doi.org/10.1007/S00415-019-09270-8

Massey JC; Sutton IJ; Ma DDF; Moore JJ, 2018, 'Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant', Frontiers in Immunology, 9, http://dx.doi.org/10.3389/fimmu.2018.00410

Godlewska A; Rose J; Schaefli L; Freake S; Massey J, 2017, 'First Nations, Métis and Inuit presence in the Newfoundland and Labrador curriculum', Race Ethnicity and Education, 20, pp. 446 - 462, http://dx.doi.org/10.1080/13613324.2016.1248825

Massey J, 2017, 'Posterior reversible encephalopathy syndrome (PRES) with sub-arachnoid haemorrhage after bevacizumab and 5-FU', Journal of Clinical Neuroscience, 40, pp. 57 - 59, http://dx.doi.org/10.1016/j.jocn.2017.01.005

Massey J; Kumar K; Ng K; Yun J; Fernando S, 2017, 'Skeletal myositis as the sole feature of relapsing drug reaction with eosinophilia and systemic symptoms syndrome', Annals of Allergy Asthma and Immunology, 118, pp. 726 - 728, http://dx.doi.org/10.1016/j.anai.2017.03.007

McCaughan G; Massey J; Sutton I; Curnow J, 2017, 'Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis', BMJ Case Reports, 2017, http://dx.doi.org/10.1136/bcr-2017-223016

Massey J, 2017, 'IgG4-related hypertrophic pachymeningitis coexpressing antineutrophil cytoplasmic antibodies', Neurology Neuroimmunology and Neuroinflammation, 4, http://dx.doi.org/10.1212/NXI.0000000000000341

Sulak TN; Massey J; Thomson D, 2017, 'Using Latent Profile Analysis to Harness the Heterogeneity of Nonretained College Students', Journal of College Student Retention Research Theory & Practice, 18, pp. 457 - 473, http://dx.doi.org/10.1177/1521025115611385

Godlewska A; Schaefli L; Massey J; Freake S; Adjei JK; Rose J; Hudson C, 2017, 'What do first‐year university students in Newfoundland and Labrador know about Aboriginal peoples and topics?', Canadian Geographies / Géographies canadiennes, 61, pp. 579 - 594, http://dx.doi.org/10.1111/cag.12428

Massey J; Buckland ME; Barnett Y; Sutton I, 2016, 'Expanding the range of immunopathology in neuromyelitis optica spectrum disorder', BMJ Case Reports, 2016, http://dx.doi.org/10.1136/bcr-2016-215981

Yun J; Cai F; Massey J; Brewer J; Kumar K; Fernando SL, 2016, 'ASCIA‐P76: SULPHASALAZINE‐INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) ASSOCIATED WITH NECROTISING EOSINOPHILIC MYOSITIS – A NOVEL FINDING', Internal Medicine Journal, 46, pp. 28 - 28, http://dx.doi.org/10.1111/imj.76_13197

Watts J; Brew B; Tisch S, 2015, 'Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria', Journal of Clinical Neuroscience, 22, pp. 1979 - 1981, http://dx.doi.org/10.1016/j.jocn.2015.05.032

Massey J; Brooks M; Burrow J, 2014, 'Evaluating the Effectiveness of Mental Health First Aid Training Among Student Affairs Staff at a Canadian University', Journal of Student Affairs Research and Practice, 51, pp. 323 - 336, http://dx.doi.org/10.1515/jsarp-2014-0032

Massey J; Field S; Chan Y, 2014, 'Partnering for economic development: How town-gown relations impact local economic development in small and medium cities', CANADIAN JOURNAL OF HIGHER EDUCATION, 44, pp. 152 - 169

Massey J; Sulak T; iram R, 2013, 'Influences of Theory and Practice in the Development of Servant Leadership in Students', Journal of Leadership Education, 12, pp. 74 - 91, http://dx.doi.org/10.12806/v12/i1/74

Massey J; Sulak T; Sriram R, 2013, 'Influences of Theory and Practice in the Development of Servant Leadership in Students', Journal of Leadership Education, 12, pp. 74 - 91, http://dx.doi.org/10.12806/v12/i1/r5

Finlay J; Massey J, 2012, 'Eco‐campus: applying the ecocity model to develop green university and college campuses', International Journal of Sustainability in Higher Education, 13, pp. 150 - 165, http://dx.doi.org/10.1108/14676371211211836

Back to profile page